OBIOOrchestra BioMed Holdings, Inc.vs its industry peers
A metric-by-metric comparison of Orchestra BioMed Holdings, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OBIO본 종목 | $340M#7 | — | 3.4x#7 | 10.2x#12 | 1169.2%#1 | 13.6%#8 | -154.7%#13 | -52.8%#9 | -54.9%#10 | — | 51.1%#2 | 5.9%#2 |
| SSII | $457M#1 | — | 8.6x#9 | 10.8x#13 | 105.7%#2 | 36.7%#4 | -19.3%#7 | -22.7%#7 | -20.1%#5 | — | — | — |
| NPCE | $428M#2 | — | 36.0x#12 | 4.3x#6 | 25.1%#4 | 20.9%#7 | -16.3%#6 | -180.6%#12 | -28.0%#7 | 4#4 | — | — |
| SI | $407M#3 | 0.1x#1 | 3.3x#6 | 8.6x#11 | 49.6%#3 | -158.4%#12 | -55.6%#10 | -32.5%#8 | -22.9%#6 | 3#7 | 73.6%#1 | — |
| OFIX | $360M#4 | — | 0.8x#2 | 0.4x#2 | 2.9%#7 | 26.8%#5 | -9.9%#5 | -21.5%#5 | -14.9%#4 | 5#2 | — | — |
| EMBC | $349M#5 | 4.2x#2 | — | 0.3x#1 | -3.8%#9 | 21.8%#6 | 22.4%#2 | — | 27.0%#1 | 6#1 | — | 10.0%#1 |
| MOBI | $344M#6 | — | 2.0x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| CLPT | $311M#8 | — | 11.4x#11 | 8.4x#10 | 17.8%#5 | -35.0%#11 | -65.4%#12 | -93.7%#11 | — | — | — | — |
| TMCI | $280M#9 | — | 4.1x#8 | 1.3x#3 | 1.6%#8 | -5.8%#9 | -25.5%#8 | -87.1%#10 | -47.4%#9 | 2#8 | — | — |
| CTSO | $258M#10 | — | — | 7.0x#9 | 4.1%#6 | 60.4%#3 | -39.8%#9 | — | -122.1%#11 | 4#4 | — | — |
| ANIK | $257M#11 | — | 1.9x#4 | 2.3x#5 | -5.9%#11 | 80.4%#2 | -9.8%#4 | -8.0%#4 | -8.8%#3 | 4#4 | — | — |
| OSUR | $248M#12 | — | 0.8x#1 | 2.2x#4 | -38.1%#13 | -252.5%#13 | -62.6%#11 | -21.6%#6 | -43.8%#8 | — | — | — |
| IDXG | $240M#13 | 9.9x#3 | 10.3x#10 | 6.2x#8 | -17.5%#12 | 267.2%#1 | 10.5%#3 | 105.8%#1 | 14.2%#2 | 5#2 | — | — |
| UTMD | $226M#14 | 21.6x#4 | 1.8x#3 | 5.9x#7 | -5.8%#10 | -18.7%#10 | 29.6%#1 | 9.2%#2 | — | — | — | 1.8%#3 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice